Constructing a Selection Biomarker Panel in the CardiAMP Autologous Cell Therapy Phase III HFrEF & Phase III Chronic Myocardial Ischemia Programs

Time: 3:00 pm
day: Conference Day 2


  • Patient selection biomarker assessment for autologous cell therapy
  • Considerations in the development and use of a biomarker panel
  • Logistics of implementation